New hope for brain cancer: experimental drug tested in small trial
NCT ID NCT06650605
First seen Apr 07, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This early-stage trial tested a new drug called I-123 ATT001 in 7 adults whose glioblastoma (a type of brain cancer) had come back. The drug was given directly into the brain through a special tube. The main goal was to check if the drug is safe and to find the right dose. This study is complete and helps researchers understand how the drug works in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University College London Hosptial
London, United Kingdom
-
University Hospital Southampton
Southampton, United Kingdom
Conditions
Explore the condition pages connected to this study.